Clinical diagnostics of cardiovascular diseases (CVD) supported by lipoprotein particle analysis
From a single serum sample, we quantify multiple biomarkers — known and newly discovered. Advanced. Automated. Affordable.
Learn more
Using FDA-cleared technology, the AXINON®System is our core platform. It incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy.
Clinical diagnostics of cardiovascular diseases (CVD) supported by lipoprotein particle analysis